Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Type II diabetes mellitus | R-HSA-2127377 | map04930 | betulinic acid | 4632 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | betulinic acid | 4632 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | betulinic acid | 4632 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | betulinic acid | 4632 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | betulinic acid | 4632 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | amantadine | 2130 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | amantadine | 2130 | drug-path |
Non-homologous end-joining | R-HSA-5693571 | map03450 | amantadine | 2130 | drug-path |
Type II diabetes mellitus | R-HSA-2127377 | map04930 | amantadine | 2130 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | primaquine | 26596 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | primaquine | 26596 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | primaquine | 26596 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | primaquine | 26596 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | primaquine | 26596 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | primaquine | 26596 | drug-path |
Asthma | R-HSA-444620 | map05310 | primaquine | 26596 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | primaquine | 26596 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | primaquine | 26596 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | primaquine | 26596 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | primaquine | 26596 | drug-path |